Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ).
Asymchem Laboratories reported a strong financial performance for the first half of 2025, with a 20.08% increase in revenue and a 23.71% rise in net profit attributable to shareholders compared to the same period in 2024. The company’s gross profit margin improved to 43.26%, and its adjusted net profit margin saw a significant increase to 21.38%. These results indicate robust growth and enhanced profitability, reflecting positively on Asymchem’s operational efficiency and market positioning.
The most recent analyst rating on (HK:6821) stock is a Buy with a HK$55.23 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in China, operating in the pharmaceutical industry. The company specializes in providing contract development and manufacturing services for the pharmaceutical sector, focusing on innovative drug development and production.
Average Trading Volume: 897,959
Technical Sentiment Signal: Buy
Current Market Cap: HK$39.74B
See more data about 6821 stock on TipRanks’ Stock Analysis page.